chapter
primarili
compon
volunt
blood
donat
transfus
singl
unit
usual
singl
donat
pint
whole
blood
virtual
alway
separ
centrifug
unit
red
blood
cell
unit
plasma
unit
platelet
unit
cryoprecipit
plasma
also
prepar
done
less
half
whole
blood
donat
sinc
patient
clinic
need
platelet
cryoprecipit
plasma
much
less
patient
need
red
blood
cell
transfus
unit
label
regul
drug
follow
fda
regul
today
virtual
blood
compon
whole
blood
donat
volunt
donor
fda
would
permit
pay
donor
requir
compon
label
mark
conspicu
word
paid
donor
oppos
volunt
donor
whole
blood
donat
permit
often
everi
eight
week
prevent
develop
iron
defi
cienci
donor
plasma
separ
red
blood
cell
unit
need
direct
transfus
patient
provid
recov
plasma
larg
multin
forprofi
compani
pool
fraction
plasma
deriv
major
sourc
plasma
plasma
deriv
manufactur
howev
sourc
plasma
collect
plasmapheresi
whole
blood
collect
us
well
mani
countri
sourc
plasma
collect
donor
paid
ie
volunt
unit
sourc
plasma
label
paid
donor
plasmapheresi
today
autom
procedur
blood
remov
donor
red
cell
return
plasma
retain
outsid
bodi
donor
may
undergo
procedur
often
twice
week
sourc
plasma
ten
thousand
donat
pool
plasma
fraction
util
seri
complex
process
chemic
physic
separ
plasma
lot
sever
plasma
deriv
includ
albumin
gamma
globulin
sometim
factor
viii
factor
ix
concentr
use
develop
part
world
treat
patient
hemophilia
b
respect
well
alpha
antitrypsin
current
process
plasma
fraction
includ
sever
purifi
steril
step
render
deriv
essenti
safe
even
though
sourc
materi
pool
plasma
thousand
paid
donor
donat
though
still
test
hepat
b
c
well
hiv
prior
avail
hiv
hepat
c
test
prior
addit
steril
step
plasma
fraction
larg
number
patient
hemophilia
regularli
expos
hepat
c
hiv
result
number
nation
scandal
law
suit
see
p
neglig
human
error
fail
oversight
today
us
patient
hemophilia
b
treat
synthet
prepar
factor
viii
factor
ix
respect
view
essenti
viral
safe
also
much
expens
steril
step
use
plasma
fraction
suit
singl
blood
compon
use
direct
transfus
sinc
process
would
damag
red
blood
cell
platelet
whole
plasma
compon
would
effi
caciou
discard
use
accomplish
throughout
sub
saharan
africa
world
health
organ
estim
hivcontamin
blood
still
account
percent
hiv
infect
throughout
region
heyn
et
al
dr
bernard
fantu
establish
fi
rst
blood
bank
unit
state
cook
counti
hospit
chicago
also
credit
coin
term
blood
bank
describ
laboratori
capabl
preserv
store
blood
year
bloodbank
spread
across
unit
state
europ
process
fraction
break
plasma
albumin
gamma
globulin
discov
product
soon
avail
clinic
use
world
war
ii
creat
immedi
demand
blood
around
time
american
red
cross
start
use
vacuum
bottl
collect
store
donat
blood
whole
blood
donat
test
abo
rh
type
well
syphili
meanwhil
unit
state
govern
set
nationwid
program
collect
blood
plasma
britain
program
aid
british
war
effort
war
albumin
use
treat
shock
coomb
test
discov
acid
citrat
dextros
acd
solut
came
use
prolong
shelflif
therebi
make
blood
avail
transfus
world
war
ii
succeed
year
blood
center
establish
across
unit
state
develop
nation
american
associ
blood
bank
aabb
establish
mission
promot
safe
bloodbank
improv
public
profession
educ
fuel
advanc
medic
care
like
openheart
surgeri
trauma
care
steadi
increas
demand
blood
compon
therapi
came
medic
practic
fi
rst
red
blood
cell
plasma
later
platelet
cryoprecipit
antihemophil
factor
ahf
transfus
today
blood
transfus
patient
essenti
one
compon
whole
blood
ie
red
cell
platelet
plasma
whole
blood
rare
transfus
approach
benefi
cial
two
respect
clinic
better
individu
patient
receiv
compon
need
expos
potenti
advers
effect
unrel
compon
also
permit
sever
patient
benefi
unit
donat
whole
blood
addit
optim
storag
condit
differ
differ
blood
compon
red
cell
refriger
plasma
frozen
platelet
agit
room
temperatur
four
differ
compon
may
deriv
one
unit
blood
nowaday
rare
three
prepar
give
blood
rel
painless
rare
circumst
free
seriou
advers
consequ
fl
uid
lost
usual
replac
natur
within
hour
take
two
month
replac
lost
red
blood
cell
whole
blood
donat
everi
eight
week
day
multipl
unit
platelet
collect
frequent
everi
two
week
procedur
call
platelet
pheresi
two
three
unit
plasma
collect
time
plasmapheresi
even
frequent
howev
two
unit
red
blood
cell
safe
donat
everi
week
also
plasmaapheresi
past
four
decad
enorm
improv
safeti
blood
suppli
overal
risk
acquir
transfusiontransmit
infect
unit
state
drop
one
one
million
unit
transfus
mirror
risk
acquir
specifi
c
infecti
agent
like
hepat
b
c
exampl
risk
acquir
hepat
b
viru
drop
unit
transfus
dodd
tabl
illustr
risk
acquir
hbv
tabl
illustr
current
estim
risk
acquir
hiv
hepat
b
c
htlv
ii
via
transfus
tabl
estim
risk
acquir
agent
compar
life
risk
sport
accid
ill
schreiber
et
al
person
far
like
die
motorcycl
accid
rock
climb
receiv
blood
transfus
test
infect
mainli
involv
measur
antibodi
viru
import
recent
addit
blood
safeti
came
nucleic
acid
amplifi
cation
test
nat
employ
new
technolog
specifi
calli
detect
small
amount
genet
materi
virus
like
hcv
hiv
west
nile
viru
wnv
infecti
agent
transmiss
transfus
around
mani
year
gener
prior
donor
activ
determin
whether
unit
blood
infect
occasion
new
microb
like
human
immunodefi
cienci
viru
hiv
babesia
microti
introduc
west
nile
viru
may
africa
time
fi
rst
identifi
ed
recent
unit
state
regardless
whether
ancient
new
agent
similar
human
activ
like
underpin
entri
transmiss
along
medic
blood
suppli
includ
intraven
drug
use
needleshar
highrisk
multipl
partner
sexual
activ
exposur
insect
vector
travel
popul
migrat
medic
neglig
may
infl
uenc
econom
polit
social
condit
subject
discuss
elsewher
volum
chapter
focu
specifi
c
impact
blood
safeti
far
greatest
challeng
blood
safeti
today
develop
world
primarili
sub
saharan
africa
part
asia
consequ
inadequ
resourc
date
technolog
health
sector
result
epidem
transfusionrel
hiv
hepat
infecti
diseas
fail
test
donat
blood
infecti
agent
thought
caus
million
hbv
infect
million
hcv
infect
case
hiv
worldwid
heyn
et
al
world
health
assembl
wha
resolut
call
countri
adopt
nation
coordin
voluntari
blood
transfus
servic
far
fewer
percent
signatori
state
done
contrast
develop
nation
made
deliber
polici
ignor
cost
order
emphas
safeti
result
steadi
increas
transfus
safeti
cost
unit
state
food
drug
administr
usfda
regul
bloodbank
sever
decad
howev
around
fda
also
start
appli
regul
pharmaceut
manufactur
bloodbank
also
mission
protect
public
health
permit
consid
cost
promulg
rule
conduct
oversight
even
though
proven
costeffect
fda
approv
interim
basi
antigen
test
hiv
fda
time
look
ahead
effect
nat
test
would
avail
still
one
studi
estim
cost
million
prevent
one
case
transfusionrel
hiv
heyn
et
al
current
nat
routin
perform
detect
hepat
c
viru
hcv
west
nile
viru
figur
illustr
steadi
rise
price
bloodbank
servic
due
part
increas
test
also
note
earlier
year
blood
center
tradit
underpr
cost
provid
red
cell
transfus
challeng
make
widespread
test
commonplac
countri
cost
limit
factor
current
advanc
test
hiv
hcv
bacteri
cultur
test
platelet
avail
develop
countri
rel
lowcost
lowtechnolog
public
health
strategi
continu
fi
rstline
import
defens
protect
blood
safeti
includ
establish
altruist
system
blood
donat
effect
public
educ
rigor
profession
train
continu
epidemiolog
surveil
consist
frontlin
screen
test
prospect
donor
give
blood
array
accur
laboratori
screen
test
continu
grow
probabl
fair
predict
never
fulli
effect
laboratori
test
everi
infecti
agent
transmit
via
blood
transfus
environ
infecti
microb
alway
chang
ecolog
human
activ
spread
therefor
realist
expect
next
infecti
agent
present
asymptomat
blood
donor
test
sourc
risk
includ
donor
infecti
yet
posit
avail
test
infect
immunosil
lab
error
erupt
new
infecti
agent
new
variant
known
agent
realiti
mind
continu
epidemiolog
surveil
uncov
chang
diseas
pattern
willing
creativ
dilig
rapid
adapt
new
challeng
key
maintain
public
health
addit
learn
outset
aid
epidem
public
health
measur
adapt
ethic
legal
paramet
pluralist
societi
challeng
maintain
suffi
cient
blood
suppli
lifesav
medic
need
constantli
chang
demand
alway
increas
long
ago
concern
relat
discrimin
vulner
stigmat
group
today
concern
reject
peopl
travel
live
western
europ
unit
state
fulli
voluntari
system
collect
center
unit
state
stop
pay
blood
late
came
clear
reduct
transmiss
hepat
transfus
earli
unit
state
risk
approxim
percent
contract
form
hepat
transfus
risk
becom
infect
hepat
b
risk
acquir
hepat
c
less
unit
transfus
remark
improv
reduc
posttransfus
hepat
may
consid
marker
overal
blood
safeti
occur
onward
us
nation
shift
voluntari
blood
donat
appreci
role
voluntari
donat
improv
help
note
time
australia
antigen
test
hbsag
assay
hepat
b
introduc
howev
australian
antigen
test
detect
hepat
c
previous
call
non
anon
b
hcv
transmiss
declin
year
seem
reason
conclud
voluntari
donat
work
institut
unit
state
continu
pay
certain
blood
donor
last
stop
practic
past
year
sinc
believ
blood
compon
transfus
us
come
volunt
sourc
summari
critic
area
chang
develop
world
wellestablish
voluntari
donor
system
still
exist
consequ
much
higher
rate
transfusionrel
infect
countri
due
agent
like
hiv
hepat
b
c
chaga
diseas
found
america
respons
public
health
problem
world
health
organ
strongli
advoc
member
state
promot
nation
blood
transfus
servic
base
voluntari
nonremuner
donat
promulg
law
govern
oper
see
also
may
world
health
assembl
resolut
wha
problem
isol
africa
europ
note
spread
hivaid
epidem
make
issu
voluntari
donat
primari
concern
mani
countri
european
region
latest
data
show
western
europ
blood
donat
mainli
nonremuner
hiv
preval
declin
regularli
time
per
donat
eastern
europ
nation
blood
suppli
mainli
base
paid
famili
replac
donor
hiv
preval
increas
alarmingli
last
year
time
compar
western
european
countri
anoth
element
fi
rstline
defens
system
effect
public
educ
health
screen
unit
state
estim
year
less
percent
individu
elig
donat
blood
actual
donor
must
good
health
weigh
least
pound
least
year
age
state
permit
donor
age
parent
approv
blood
bank
upper
age
limit
increas
number
senior
give
blood
get
voluntari
donor
requir
appeal
individu
selfinterest
commun
spirit
american
red
cross
public
educ
messag
point
us
face
time
great
vulner
need
blood
time
often
unexpect
american
red
cross
effect
public
media
campaign
also
involv
educ
individu
need
voluntari
exclus
peopl
highrisk
group
poor
health
tri
donat
blood
present
unit
state
guidelin
inelig
includ
food
drug
administr
prior
histori
illeg
intraven
drug
use
man
sexual
contact
anoth
man
msm
sinc
howev
current
reconsid
propos
accept
msm
msm
activ
last
year
histori
receiv
clottingfactor
concentr
posit
hiv
test
histori
engag
sex
money
drug
sinc
histori
hepat
sinc
age
histori
babesiosi
chaga
diseas
ever
taken
tegison
psoriasi
risk
factor
crueutzfeldtjakob
diseas
cjd
includ
famili
member
cjd
receipt
dura
mater
transplant
administr
human
pituitari
deriv
growth
hormon
andor
transmiss
via
reusabl
instrument
employ
brain
surgeri
risk
factor
variant
creutzfeldtjacob
diseas
vcjd
includ
three
month
spent
unit
kingdom
fi
year
spent
europ
present
public
health
prevent
also
includ
identifi
refrain
collect
blood
highrisk
locat
prison
mental
health
facil
highrisk
hepat
even
though
effect
test
hiv
contamin
avoid
commun
set
rel
high
concentr
men
sex
men
risk
hiv
infect
polici
controversi
educ
materi
provid
advanc
contain
clear
specifi
c
instruct
list
exclus
give
blood
recent
travel
geograph
locat
malaria
endem
resid
europ
variant
creutzfeldtjacob
diseas
vcjd
present
see
upon
enter
blood
collect
center
prospect
donor
given
written
materi
inform
risk
symptom
associ
infecti
diseas
transmit
blood
transfus
ask
question
given
form
sign
indic
read
understood
materi
provid
accur
person
inform
question
also
ask
donor
safeti
medic
histori
heart
diseas
current
fever
sign
infecti
diseas
point
elect
leav
without
give
blood
donor
ask
clear
specifi
c
question
behavior
increas
risk
carri
infecti
agent
transmit
transfus
inject
drug
sexual
activ
recent
tattoo
travel
question
updat
need
account
chang
infecti
diseas
epidemiolog
exampl
respons
newli
emerg
aid
epidem
earli
blood
collect
center
began
ask
men
sexual
contact
men
even
though
viru
yet
isol
determin
caus
aid
populationbas
data
show
new
diseas
behav
like
hepat
b
alreadi
well
known
caus
viru
spread
sexual
activ
share
intraven
needl
recreat
drug
use
blood
transfus
gener
public
health
approach
continu
effect
screen
measur
populationbas
data
point
conclus
anoth
direct
rare
discontinu
strict
applic
screen
protocol
convinc
data
sustain
period
time
thu
sever
year
haitian
unit
state
stop
consid
separ
risk
group
hiv
unit
state
polici
gener
screen
individu
behavior
group
ethnic
fi
rst
instruct
identifi
aid
promulg
januari
march
laboratori
test
becam
avail
screen
hiv
donat
blood
test
develop
within
year
made
avail
donor
screen
prior
largescal
experi
screen
test
confi
rmatori
test
western
blot
accordingli
experi
develop
million
blood
donat
test
inform
regard
falseposit
rate
becam
avail
test
modifi
ed
next
year
improv
specifi
citi
still
screen
question
chang
solid
epidemiolog
inform
becam
avail
donor
posit
test
result
interview
specifi
c
criteria
western
blot
posit
began
develop
look
individu
consid
western
blotposit
risk
factor
diseas
exclus
polici
revis
ask
donor
specifi
c
question
behavior
guidelin
recent
revis
tattoo
done
statebyst
basi
base
state
regul
tattoo
facil
month
american
red
cross
monitor
true
posit
rate
infecti
diseas
marker
sinc
begin
hiv
test
clear
downward
trend
unit
confi
rm
posit
hiv
dodd
refl
ect
improv
donor
screen
also
new
activ
coordin
agenc
organ
weekli
surveil
west
nile
viru
posit
blood
donor
posit
actual
preced
cdc
identifi
cation
human
case
west
nile
viru
diseas
situat
coordin
bloodbank
gener
epidemiolog
posit
synergist
impact
public
health
sinc
posit
test
blood
donor
follow
individu
local
blood
region
local
increas
confi
rmed
posit
suggest
local
epidem
follow
local
public
health
entiti
local
public
health
depart
notifi
local
red
cross
chang
diseas
epidemiolog
blood
collect
center
refrain
blood
collect
drive
potenti
epidem
situat
past
year
prolifer
new
better
laboratori
test
infecti
diseas
transmit
transfus
blood
product
test
antibodi
treponema
pallidum
bacterium
caus
syphili
australian
antigen
hepat
b
surfac
antigen
hbsag
addit
test
develop
hepat
b
c
hiv
htlvi
test
parasit
discuss
mani
year
fda
yet
licens
test
screen
malaria
chaga
diseas
risk
contamin
viral
agent
diminish
greater
emphasi
develop
assay
parasit
unit
state
polici
screen
unit
blood
soon
new
assay
licens
current
includ
follow
laboratori
test
see
tabl
approv
laboratori
test
conduct
donat
either
new
better
test
licens
populationbas
data
indic
longer
product
exampl
alt
test
hepat
continu
discontinu
specifi
c
sensit
test
becam
avail
detect
hcv
similarli
antigen
test
discontinu
specifi
c
sensit
nucleic
acid
amplifi
cation
test
nat
licens
ad
routin
donor
screen
march
march
antigen
test
perform
approxim
unit
even
addit
neutral
test
mani
falseposit
test
result
still
test
continu
period
fi
donor
found
hivantigen
posit
hivantibodi
neg
million
unit
test
current
unit
state
note
cmv
test
perform
unit
blood
patient
requir
cmvneg
blood
exampl
neonat
weigh
less
g
immunocompromis
immunesuppress
patient
sourc
american
red
cross
http
wwwpleasegivebloodorgeducationbloodtestedphp
countri
test
hivrna
unit
kingdom
other
test
hcvrna
hivrna
estim
rna
test
reduc
risk
hiv
hcv
transmiss
million
blood
unit
note
differ
laboratori
test
avail
blood
test
licens
clinic
assess
patient
exampl
diagnost
clinic
test
chaga
diseas
malaria
still
none
licens
screen
blood
contrast
laboratori
test
licens
blooddonor
screen
approv
patient
use
may
john
paul
ii
shot
critic
wound
assassin
attempt
fi
vehour
surgic
procedur
rome
hospit
repair
wound
pope
given
six
pint
blood
june
hospit
high
fever
infl
ammat
right
lung
pope
test
found
infect
cytomegaloviru
cmv
herpestyp
viru
transmit
sexual
contact
blood
transfus
acquir
cmv
blood
administ
surgeri
time
neither
italian
law
standard
medic
practic
requir
transfus
unit
test
cmv
cathol
news
servic
number
year
later
fi
ltere
white
blood
cell
blood
compon
came
common
use
reduc
risk
cmv
transfus
pope
john
paul
experi
illustr
link
human
behavior
transfus
risk
number
infecti
agent
associ
human
highrisk
sexual
behavior
inject
drug
use
special
concern
safeti
blood
suppli
fi
rst
identifi
ed
syphili
test
began
world
war
ii
time
rate
syphili
infect
much
higher
gener
popul
howev
risk
acquir
syphili
via
blood
transfus
present
exceedingli
small
fact
unit
state
record
case
transmit
transfus
mani
year
one
report
literatur
poorli
document
case
syphili
transmit
transfus
moreov
spirochet
caus
syphili
fragil
becom
inact
fi
rst
day
refriger
blood
storag
said
hepat
b
hiv
htlv
cmv
howev
infect
spread
sexual
also
transmit
transfus
sinc
recogn
late
blood
transfus
could
transmit
hiv
increas
intern
attent
link
sexual
activ
inject
illicit
drug
blood
safeti
epidem
relat
highrisk
sexual
activ
sex
work
trade
sex
drug
discuss
chapter
epidem
relat
intraven
drug
use
discuss
chapter
type
behavior
known
impact
safeti
blood
suppli
especi
donor
paid
blood
ideal
medium
harbor
grow
transmit
agent
spread
behavior
hiv
hepat
b
c
virus
htlv
cmv
other
combat
problem
feder
red
cross
red
crescent
societi
call
expand
drug
abus
prevent
harm
reduct
public
educ
believ
nation
societi
uniqu
combin
volunt
support
commun
membership
alongsid
statu
auxiliari
public
author
humanitarian
fi
eld
special
contribut
make
best
approach
challeng
nation
commun
level
kopketzki
two
decad
intern
attent
aid
epidem
hiv
like
hepat
b
viru
known
spread
sexual
contact
ivdu
note
fi
countri
former
soviet
union
asia
combin
popul
almost
billion
see
hiv
epidem
regist
case
per
countri
wolf
malinowskasempruch
epidem
associ
highrisk
human
sexual
activ
inject
drug
use
nation
also
limit
safeti
control
blood
bank
even
improv
laboratori
screen
frontlin
defens
state
develop
nation
effect
public
health
screen
us
guidelin
relat
directli
uncov
highrisk
sexual
activ
ivdu
also
exclud
individu
aid
posit
hiv
test
addit
exclud
individu
histori
inject
illicit
drug
includ
steroid
medic
prescrib
physician
man
sinc
sex
anoth
man
even
anyon
sinc
ever
taken
money
drug
payment
sex
anyon
sinc
born
live
receiv
transfus
medic
treatment
cameroon
central
african
republ
chad
congo
equatori
guinea
gabon
niger
nigeria
sexual
contact
past
month
anyon
describ
type
rare
form
hiv
found
primarili
west
africa
write
laboratori
test
approv
unit
state
detect
type
donat
blood
unit
state
food
drug
administr
promulg
rule
prohibit
blood
donat
individu
born
west
african
state
person
sexual
contact
someon
born
one
nation
sinc
travel
migrat
trade
expand
rapidli
globe
movement
countri
blood
compon
transfus
still
rel
uncommon
date
blood
suppli
develop
nation
remain
remark
immun
infect
travel
migrat
exampl
estim
million
peopl
malaria
perhap
hand
case
year
unit
state
due
infect
via
blood
suppli
similarli
chaga
diseas
endem
mexico
central
south
america
million
peopl
countri
travel
annual
america
report
incid
chaga
diseas
due
blood
transfus
unit
state
low
chamberland
et
al
nevertheless
concern
real
blood
extraordinarili
effect
vehicl
transmit
infecti
agent
chamberland
et
al
sinc
fulli
effect
laboratori
test
everi
bloodtransmiss
infecti
diseas
world
horizon
current
fi
rst
line
defens
remain
effect
health
screen
public
educ
individu
give
blood
also
hope
note
new
laboratori
test
screen
human
blood
develop
note
alreadi
wake
improv
screen
test
infect
transmiss
transfus
see
greater
emphasi
develop
screen
parasit
eg
chaga
diseas
malaria
infect
blood
suppli
even
popul
shift
blood
suppli
develop
nation
remain
remark
safe
illustr
tabl
show
low
rate
transfusionrel
infect
due
malaria
cruzi
infect
endem
unit
state
well
babesiosi
endem
us
center
diseas
control
record
case
transfusiontransmit
malaria
unit
state
malaria
endem
north
america
case
like
result
blood
donat
peopl
asymptomat
carrier
unit
state
potenti
donor
screen
questionnair
ask
refrain
give
blood
one
year
visit
malari
area
three
year
complet
treatment
malaria
three
year
live
area
endem
rare
us
malaria
epidem
tropic
area
caus
seriou
health
consequ
includ
death
practic
test
avail
screen
donor
tabl
illustr
us
estim
malaria
contamin
blood
suppli
current
small
unit
fatal
howev
problem
wholli
differ
tropic
countri
particularli
sub
saharan
africa
worldwid
malaria
signifi
cant
caus
death
due
parasit
infect
world
health
organ
estim
least
million
acut
case
malaria
year
global
lead
million
death
probabl
percent
death
occur
africa
mostli
young
children
blood
transfus
use
treat
lifethreaten
malaria
young
children
also
pose
risk
acquir
hiv
infect
obonyo
et
al
cjd
rare
degen
fatal
disord
central
nervou
system
worldwid
incid
one
person
per
million
per
year
cjd
affect
human
three
way
sporad
cjd
known
risk
factor
account
percent
cjd
case
hereditari
cjd
occur
individu
famili
histori
diseas
test
posit
specifi
c
genet
mutat
acquir
cjd
transmit
exposur
brain
nervou
system
tissu
acquir
cjd
account
less
percent
cjd
case
occur
individu
receiv
repeat
inject
human
pituitari
gland
growth
hormon
prepar
prepar
pool
pituitari
gland
number
cadav
use
treat
congenit
dwarfi
sm
although
practic
subsequ
supplant
synthet
growth
hormon
prepar
cjd
also
transmit
patient
undergon
brain
surgeri
includ
transplant
dura
mater
cover
brain
spinal
cord
materi
harvest
human
cadav
use
brain
oper
dura
mater
store
vat
along
dura
mater
cadav
contamin
materi
affect
individu
may
take
decad
develop
symptom
progress
rapidli
dementia
sever
loss
coordin
death
caus
cjd
remain
uncertain
suspicion
occur
respons
abnorm
chang
shape
brain
prion
current
screen
test
diseas
blood
transfus
never
shown
transmit
cjd
precaut
food
drug
administr
fda
prohibit
blood
donat
individu
may
risk
includ
potenti
donor
receiv
inject
humanderiv
pituitari
hormon
famili
histori
cjd
surgeri
involv
transplant
dura
mater
similar
cjd
issu
regard
travel
variant
creutzfeldtjacob
diseas
vcjd
also
rare
degen
similar
fatal
disord
central
nervou
system
thought
occur
human
eaten
beef
contamin
bovin
spongiform
encephalopathi
bse
mad
cow
diseas
fi
rst
case
vcjd
report
unit
kingdom
soon
concern
part
blood
bank
public
health
offi
cial
could
contamin
blood
suppli
date
problem
remain
quit
rare
case
unit
kingdom
uk
franc
itali
one
case
unit
state
person
live
uk
period
greatest
risk
far
recent
two
case
uk
presum
transmit
via
blood
transfus
usfda
polici
seek
strike
reason
balanc
guard
risk
spread
vcjd
bloodbank
preserv
suppli
blood
product
medic
use
current
polici
relat
travel
resid
europ
recommend
follow
individu
defer
indefi
nite
spent
total
three
month
unit
kingdom
uk
begin
end
spent
total
fi
year
europ
present
current
former
us
militari
personnel
civilian
militari
employe
depend
resid
us
militari
base
northern
europ
germani
uk
belgium
netherland
total
six
month
resid
elsewher
europ
greec
turkey
spain
portug
itali
receiv
blood
blood
compon
transfus
uk
present
person
inject
bovin
insulin
sinc
cattl
rais
unit
kingdom
unless
possibl
confi
rm
product
manufactur
cattl
uk
guidelin
also
issu
us
depart
defens
dod
also
relat
travel
resid
europ
recommend
activeduti
militari
personnel
civil
servic
employe
famili
member
defer
indefi
nite
give
blood
travel
resid
uk
cumul
total
three
month
time
end
receiv
blood
transfus
uk
time
present
travel
resid
anywher
europ
cumul
total
six
month
time
end
travel
resid
anywher
europ
cumul
total
fi
year
time
januari
present
polici
constant
review
fda
light
new
inform
vcjd
bse
much
discuss
develop
test
vcjd
could
use
screen
blood
donor
littl
real
progress
order
sensit
enough
identifi
virtual
potenti
infecti
donat
almost
screen
test
falseposit
rate
deal
necessari
suitabl
confi
rmatori
test
prior
begin
donor
screen
rational
risk
transmiss
transfus
small
would
unaccept
situat
notifi
fair
number
volunt
blood
donor
test
result
suggest
may
later
develop
fatal
diseas
treatment
uncertainti
mean
test
result
almost
year
ago
brazilian
physician
carlo
chaga
discov
parasit
trypanosoma
cruzi
caus
chaga
diseas
today
infect
mani
million
peopl
worldwid
establish
bodi
infect
lifelong
sever
thousand
south
central
american
die
annual
heart
digest
problem
caus
parasit
percent
infect
peopl
never
exhibit
symptom
year
chaga
diseas
often
transmit
transfus
south
america
prior
avail
test
sinc
treatment
chaga
diseas
earlier
gentian
violet
ad
directli
unit
blood
prior
transfus
recent
test
chaga
diseas
becom
routin
much
south
america
infect
remain
rare
outsid
south
central
america
come
consid
threat
blood
suppli
global
travel
migrat
especi
south
america
north
america
date
seven
case
transfusiontransmit
chaga
diseas
report
north
america
two
canada
estim
sever
million
peopl
countri
chaga
diseas
present
resid
unit
state
may
infect
cruzi
kirchoff
et
al
sever
investig
studi
us
blood
donor
confi
rmed
sensit
test
far
hand
case
blood
donor
confi
rmed
posit
test
track
donor
countri
chaga
diseas
endem
precaut
american
associ
blood
bank
guidelin
prohibit
blood
donat
anyon
chaga
diseas
laboratori
screen
test
develop
expect
approv
test
implement
routin
donat
babesiosi
parasit
infect
red
blood
cell
caus
protozoa
babesia
microti
similar
malaria
carri
whitefoot
mous
transmit
deer
tick
bite
appear
primarili
northeastern
unit
state
coastal
area
home
whitefoot
mous
case
also
identifi
ed
upper
midwest
pacifi
c
northwest
approxim
transfusionassoci
case
report
unit
state
babesiosi
often
quit
mild
patient
includ
without
spleen
elderli
immunocompromis
may
risk
seriou
ill
occasion
babesiosi
misdiagnos
malaria
correctli
diagnos
appropri
antibiot
therapi
effect
use
test
avail
screen
blood
donor
although
test
strategi
discuss
american
associ
blood
bank
aabb
requir
donor
ask
histori
babesiosi
individu
histori
diseas
defer
donat
blood
social
ecolog
lyme
diseas
relat
migrat
popul
develop
nation
suburban
area
see
chapter
associ
bite
speci
deer
tick
vector
babesiosi
caus
ill
affect
mani
system
within
bodi
despit
number
research
look
exampl
lyme
diseas
transmit
transfus
none
found
probabl
present
blood
potenti
capabl
transmit
transfus
short
period
time
one
interest
case
individu
thought
posit
lyme
diseas
babesiosi
whose
blood
donat
transmit
babesiosi
lyme
diseas
cabl
et
al
mcquiston
et
al
transfusionrel
case
report
public
health
agenc
aabb
monitor
diseas
remot
chanc
could
affect
transfus
safeti
peopl
histori
lyme
diseas
give
blood
provid
complet
full
cours
antibiot
treatment
longer
symptom
first
discov
human
ehrlichiosi
bacteri
infect
caus
sever
type
rickettsia
spread
tick
vector
dog
anim
human
like
lyme
diseas
ehrlichiosi
occur
context
widen
suburban
sprawl
north
america
europ
japan
bloodstream
bacteria
invad
kill
white
blood
cell
two
type
ehrlichiosi
human
granulocyt
hge
human
monocyt
ehrlichiosi
hme
threat
blood
suppli
appear
primarili
hge
case
hge
report
unit
state
symptom
includ
rel
mild
selflimit
fever
headach
malais
howev
percent
peopl
hge
go
suffer
enceph
acut
respiratori
distress
syndrom
opportunist
infect
percent
infect
may
fatal
treatment
antibiot
tetracylin
effect
incid
hge
well
understood
among
blood
donor
perhap
one
presumpt
case
blood
recipi
preliminari
studi
indic
hge
surviv
refriger
blood
day
walker
dumler
leibi
et
al
sar
respiratori
infect
produc
seriou
complic
case
identifi
ed
asia
outbreak
elsewher
includ
unit
state
canada
date
evid
sar
transmiss
blood
transfus
howev
potenti
exist
viru
associ
sar
present
blood
peopl
sick
possibl
viru
present
blood
individu
becom
ill
person
donat
blood
individu
potenti
could
introduc
viru
blood
suppli
prevent
occur
blood
collect
facil
ask
potenti
donor
oral
write
recent
travel
sarsaffect
countri
histori
sar
infect
possibl
exposur
sar
risk
contract
sar
blood
transfus
theoret
exist
period
sar
epidem
anywher
world
anyon
travel
sarsinfect
area
close
contact
person
sar
someon
suspect
sar
ask
refrain
donat
blood
least
day
arriv
unit
state
close
contact
defi
ned
care
live
direct
contact
respiratori
secret
andor
bodi
fl
uid
person
known
sar
anyon
ill
sar
suspect
sar
refrain
donat
blood
day
last
date
treatment
symptom
addit
donor
ask
call
blood
center
donat
becom
ill
call
occur
prior
blood
transfus
unit
intercept
destroy
long
donor
remain
well
measur
necessari
unit
state
develop
nation
error
blood
compon
prepar
test
nowaday
rare
primarili
due
barcod
donor
registr
form
blood
donat
compon
sampl
tube
well
largescal
autom
viral
test
test
blood
type
computer
assimil
test
result
pertin
blood
donat
one
type
error
still
occur
blood
collect
site
label
form
donat
andor
tube
collect
blood
two
exampl
human
error
might
occur
blood
donor
handl
separ
other
staff
person
evalu
donor
histori
turn
donor
form
anoth
staff
person
venipunctur
technician
collect
blood
tube
test
check
second
staff
person
task
ask
donor
provid
name
check
paperwork
collect
unit
check
perform
correctli
one
donor
identifi
inform
becom
associ
anoth
donor
unit
blood
donat
unit
test
result
associ
donor
subsequ
call
back
infrequ
event
say
develop
fever
learn
recent
prior
exposur
hepat
wrong
unit
blood
recal
one
recal
could
transfus
omin
error
would
mixup
whole
blood
number
associ
bar
code
one
unit
blood
number
tube
test
anoth
donat
bar
code
number
manual
place
three
four
tube
test
unit
blood
staff
person
interrupt
place
bar
code
tube
bag
wrong
tube
pick
fi
lling
collect
unit
blood
test
result
associ
wrong
unit
transfus
one
donor
test
result
posit
unit
could
still
label
accept
due
clear
test
result
donor
transfus
sinc
percent
blood
donat
repeat
donor
blood
type
prior
donat
check
label
current
donat
blood
center
probabl
know
error
occur
investig
prevent
label
releas
potenti
affect
unit
blood
type
two
donor
differ
eg
one
posit
anoth
neg
find
discrep
rare
event
due
emphasi
train
collect
staff
import
donor
ident
proper
handl
blood
sampl
unit
label
addit
hospit
requir
recheck
abo
rh
type
unit
label
blood
receiv
blood
center
issu
transfus
patient
consequ
adher
strict
procedur
fi
nding
discrep
hospit
rare
event
nevertheless
practic
continu
last
check
hospit
continu
test
tube
unit
proper
number
bar
code
test
use
donat
discard
number
highprofi
le
scandal
occur
bloodbank
develop
nation
notabl
fi
rst
year
aid
epidem
also
relat
hepat
c
one
occur
canada
canadian
red
cross
societi
import
plasma
donat
unit
state
time
wide
known
aid
epidem
unit
state
associ
blood
transfus
especi
among
peopl
hemophilia
meanwhil
canada
fulli
selfsuffi
cient
suppli
blood
product
particular
adequ
suppli
factor
viii
concentr
plasma
deriv
peopl
hemophilia
canadian
red
cross
face
diffi
cult
problem
weigh
risk
import
potenti
taint
blood
product
put
hemophiliac
risk
insuffi
cient
suppli
clot
agent
canadian
red
cross
chose
continu
import
us
suppli
howev
us
center
diseas
control
approv
test
hiv
blood
canadian
red
cross
implement
test
late
nation
scandal
erupt
critic
accus
govern
canadian
red
cross
denial
neglig
canadian
hemophilia
societi
request
compens
victim
ignor
victim
persist
feder
govern
appoint
commiss
inquiri
head
justic
horac
krever
investig
spread
hiv
hepat
c
bloodbank
system
conclud
red
cross
govern
oversight
led
failur
act
time
manner
prevent
spread
hiv
hepat
blood
suppli
system
underfund
canada
lack
strong
nation
blood
polici
clear
line
respons
across
organ
agenc
involv
entir
process
bloodbank
victim
famili
award
compens
commiss
also
conclud
donat
blood
nation
public
resourc
safeti
paramount
nation
independ
board
establish
nation
standard
promulg
red
cross
replac
new
canadian
blood
servic
manag
bloodbank
system
feder
provinci
territori
govern
announc
countri
fi
rst
nation
standard
govern
handl
blood
blood
product
veintovein
may
canadian
red
cross
apolog
plead
guilti
distribut
taint
blood
product
dr
roger
perrault
nation
medic
director
canadian
red
cross
time
scandal
three
physician
armour
pharmaceut
locat
unit
state
put
trial
crimin
neglig
proceed
continu
estim
perhap
peopl
infect
hepat
c
hiv
canada
epidem
contamin
factor
viii
concentr
product
hemophiliac
also
occur
franc
japan
scandal
also
erupt
recogn
highlevel
govern
offi
cial
either
knew
known
product
unsaf
culpabl
permit
remain
use
franc
perhap
individu
infect
three
french
offi
cial
charg
former
premier
laurent
fabiu
superior
time
social
affair
minist
georgina
dufoix
health
minist
respons
oversight
edmond
core
charg
neglig
three
delay
introduc
us
bloodscreen
test
franc
rival
french
product
readi
go
market
convict
neglig
hiv
acquir
two
recipi
product
court
fail
hand
punish
still
least
public
recognit
offi
cial
respons
bbc
news
japan
hemophiliac
expos
hiv
least
die
result
scandal
rais
nation
outcri
whether
japanes
govern
health
bureaucraci
tie
pharmaceut
industri
therebi
put
profi
ts
peopl
akihito
matsumara
head
govern
ministri
respons
handl
blood
blood
product
charg
neglig
given
suspend
oneyear
sentenc
death
patient
contract
aid
contamin
transfus
time
heat
treatment
steril
blood
replac
product
hiv
place
unit
state
two
year
bbc
news
much
larger
epidem
hiv
hepat
possibl
infecti
diseas
may
occur
china
result
unsaf
practic
unscrupul
privat
blood
collect
compani
close
link
govern
offi
cial
enterpris
oper
henan
anhui
shaanxi
hebei
provinc
mostli
poor
rural
chines
paid
donat
blood
reus
nonsteril
blood
collect
equip
donor
reinfus
repeat
donor
potenti
taint
blood
order
reduc
symptom
anemia
get
donat
often
far
never
full
surveil
program
document
extent
epidem
could
larg
combin
popul
provinc
equal
western
europ
donor
risk
also
sexual
partner
activist
protest
govern
coverup
beaten
jail
februari
proof
offi
cial
govern
particip
blood
donor
scheme
appear
form
videotap
sent
unit
nation
prc
ministri
health
news
media
show
villag
blood
donor
card
issu
henan
ministri
health
individu
allow
repeat
donor
march
approxim
seven
year
begin
epidem
nation
ministri
health
acknowledg
transmiss
hiv
occur
due
blood
collect
date
individu
chines
offi
cial
held
respons
agenc
franc
press
wan
li
maintain
safe
blood
suppli
requir
constant
vigil
part
bloodbank
public
health
offi
cial
one
could
predict
enorm
challeng
creat
aid
pandem
doubt
new
challeng
aris
year
ahead
one
rel
new
concern
terror
see
chapter
offi
cial
unit
state
concern
possibl
terrorist
could
obtain
access
smallpox
viru
use
public
vaccinia
live
viru
use
smallpox
vaccin
routin
administ
american
smallpox
highli
infecti
exampl
scab
inocul
site
contain
infecti
viru
possibl
scab
spontan
separ
skin
inadvert
infect
close
contact
touch
vaccin
site
dress
anoth
area
concern
bloodbank
respons
potenti
threat
unit
state
depart
health
human
servic
hh
work
state
local
govern
strengthen
prepared
part
strategi
expand
nation
stockpil
smallpox
vaccin
highli
effect
administ
shortli
exposur
make
certain
viru
transmit
blood
transfus
potenti
donor
ask
blood
collect
facil
histori
vaccin
close
contact
anyon
vaccin
vaccin
recipi
complic
may
donat
vaccin
scab
spontan
separ
day
vaccin
whichev
later
individu
receiv
smallpox
vaccin
may
ask
refrain
donat
interv
two
month
scab
pull
knock
ie
spontan
separ
refrain
symptomfre
day
complic
contact
vaccin
recipi
develop
skin
lesion
complic
smallpox
vaccin
administ
rapidli
larg
section
popul
would
substanti
neg
effect
blood
suppli
particularli
platelet
current
fda
recommend
individu
refrain
donat
blood
one
month
smallpox
vaccin
anoth
futur
consider
blood
safeti
pathogen
inactiv
sever
larg
corpor
spent
hundr
million
dollar
explor
differ
approach
pathogen
inactiv
red
cell
platelet
plasma
sinc
function
red
cell
platelet
plasma
protein
differ
fragil
function
must
preserv
effect
approach
involv
expos
singl
blood
compon
chemic
sometim
along
uv
light
virus
bacteria
parasit
would
inactiv
longer
infecti
process
requir
addit
inactiv
chemic
blood
wash
chemic
patient
expos
chemic
perform
inactiv
compon
would
expens
requir
larg
laboratori
would
gener
huge
volum
hazard
wast
wash
solut
due
increas
safeti
blood
transfus
occur
last
year
question
whether
small
increment
theoret
improv
safeti
worth
huge
expens
risk
staff
handl
chemic
clinic
trial
process
termin
red
cell
though
continu
platelet
tradit
conserv
group
bloodbank
sensit
patient
safeti
public
percept
regulatori
agenc
eg
fda
slow
chang
longstand
process
develop
earlier
improv
safeti
follow
tradit
test
ad
donat
question
ask
prospect
donor
donor
defer
blood
suppli
dwindl
offset
major
initi
encourag
donat
new
donor
frequent
donat
exist
suitabl
donor
continu
need
time
popular
lay
belief
artifi
cial
blood
synthet
blood
solv
problem
truli
synthet
blood
repres
perfl
uorocarbon
carri
releas
oxygen
sever
trial
discontinu
due
safeti
concern
problem
includ
benefi
cial
effect
brief
administr
percent
oxygen
requir
use
recipi
patient
blood
milki
interf
interpret
mani
clinic
laboratori
test
result
perfl
uorocarbon
role
oxygen
deliveri
supplant
need
platelet
plasma
transfus
refer
stromafre
hemoglobin
solut
artifi
cial
blood
sourc
still
blood
advantag
includ
extend
shelflif
lax
storag
condit
need
match
blood
type
presum
lack
infecti
risk
clinic
trial
halt
due
safeti
concern
well
benefi
cial
effect
recipi
shortliv
bridg
transfus
tradit
red
cell
becom
avail
bovinesourc
hemoglobin
continu
face
multipl
challeng
get
regulatori
hurdl
artifi
cial
substitut
platelet
horizon
sever
isol
plasma
protein
synthes
factor
viii
factor
ix
exampl
other
albumin
would
nt
costeffect
substitut
gamma
globulin
expect
sinc
requir
panopli
antibodi
donor
thing
donor
expos
chang
popul
expos
new
infecti
agent
make
antibodi
multipl
attempt
grow
blood
cell
tissu
cultur
propag
yet
fruit
pathogen
inactiv
may
help
maintain
safeti
addit
infecti
threat
would
expens
might
eventu
howev
permit
individu
elig
donor
variou
approach
pathogen
inactiv
appear
applic
red
cell
platelet
plasma
bottom
line
quit
time
continu
depend
altruist
voluntari
donat
peopl
often
elig
pleas
give
blood
unit
state
make
appoint
site
conveni
call
life
elig
encourag
friend
famili
acquaint
may
elig
donat
